+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Granisetron Market - Global Forecast 2026-2032- Product Image
Granisetron Market - Global Forecast 2026-2032- Product Image
Sale

Granisetron Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6017482
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Granisetron Market is projected to reach USD 8.50 Billion in 2026. It is expected to continue growing at a CAGR of 8.03%, reaching USD 13.65 Billion by 2032.

Granisetron: Clinical Role and Market Context

Granisetron is a selective serotonin 5-HT3 receptor antagonist used primarily to prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. Its clinical value is linked to reliable symptom control, multiple dosage forms, and use across hospital and outpatient settings. Assessment of this market should therefore consider treatment protocols, regulatory requirements, procurement practices, generic competition, and access to supportive-care medicines rather than relying on demand alone.

Treatment Pathways Are Shifting Toward Protocol-Based Supportive Care

Granisetron is increasingly evaluated within broader antiemetic protocols rather than as an isolated medicine. Clinical practice emphasizes matching treatment intensity to emetogenic risk, patient characteristics, and the underlying therapy. Hospitals and oncology services are also prioritizing standardized pathways, medication safety, convenient administration, and continuity between inpatient and outpatient care. These shifts increase the importance of evidence-based positioning, formulation suitability, and dependable supply.

Artificial Intelligence Is Improving Antiemetic Decisions and Operations

Artificial intelligence can support granisetron-related care by identifying patients at elevated risk of nausea and vomiting, helping clinicians align antiemetic regimens with treatment characteristics, and detecting medication-safety issues in clinical records. In supply operations, analytical tools can improve demand sensing, inventory monitoring, and identification of potential shortages. Human oversight remains essential because model outputs depend on data quality, clinical validation, privacy safeguards, and integration with prescribing workflows.

Regional Differences Reflect Regulation, Oncology Capacity, and Access

North America is shaped by established oncology infrastructure, payer scrutiny, and demand for convenient formulations. Europe places strong emphasis on health-technology assessment, generic access, and harmonized regulatory standards, while Latin America shows variation in public procurement, reimbursement, and availability between countries. In the Middle East, investment in specialist care coexists with uneven access across health systems. Africa requires attention to essential-medicine availability, supply reliability, and oncology-service capacity. Asia-Pacific combines advanced markets with rapidly expanding healthcare systems, creating substantial differences in regulation, affordability, and treatment access across the region.

Multilateral Groups Reveal Distinct Regulatory and Procurement Priorities

ASEAN markets differ in regulatory maturity, reimbursement, and hospital purchasing, making localized registration and distribution strategies important. BRICS countries combine large and diverse healthcare systems with varying domestic-manufacturing policies and access conditions. The European Union benefits from regulatory coordination while retaining national differences in pricing and procurement. G7 countries generally apply rigorous evidence, pharmacovigilance, and quality expectations. GCC members often use centralized or coordinated procurement alongside investment in specialist healthcare. NATO members span diverse health systems, so the group is most relevant as a broad indicator of preparedness, resilience, and secure pharmaceutical supply rather than a uniform commercial market.

Country Priorities Range from Access and Manufacturing to Clinical Integration

Australia emphasizes national formulary processes and hospital access; Brazil combines public-system procurement with regulatory and regional distribution complexity; Canada reflects provincial reimbursement and centralized purchasing considerations. China and India place importance on domestic pharmaceutical capabilities, regulatory compliance, and broad access. France, Germany, Italy, and Spain operate within the European regulatory framework while retaining distinct reimbursement and procurement practices. Japan and South Korea emphasize rigorous quality standards and sophisticated hospital care. Mexico faces differences between public and private access channels. Russia is influenced by domestic-supply priorities and evolving procurement conditions. The United Kingdom focuses on evidence-based commissioning and health-service procurement, while the United States is shaped by hospital formularies, payer requirements, and medication-safety expectations.

Industry Leaders Should Prioritize Evidence, Supply Resilience, and Patient Convenience

Leaders should maintain robust regulatory and pharmacovigilance systems, generate evidence that clarifies granisetron’s role within guideline-aligned antiemetic protocols, and support healthcare professionals with clear administration and safety information. Supply strategies should diversify qualified sources, strengthen quality controls, monitor critical inputs, and use data-driven early-warning systems. Portfolio planning should address relevant dosage forms and care settings without compromising clinical appropriateness. Regional execution should be tailored to reimbursement, procurement, and registration requirements, while partnerships with hospitals and oncology networks can improve implementation and responsible use.

Methodology Combines Clinical, Regulatory, and Geographic Evidence

The assessment uses a structured review of granisetron’s approved indications, clinical role, formulations, safety considerations, treatment guidelines, regulatory frameworks, procurement dynamics, and healthcare-access conditions. Findings are organized across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, then compared across ASEAN, BRICS, the European Union, G7, GCC, and NATO groupings. Country analysis covers Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and the United States. Interpretation prioritizes verifiable public evidence and avoids unsupported quantitative claims.

Granisetron’s Outlook Depends on Integration into Reliable Supportive Care

Granisetron remains relevant where prevention and management of treatment-related nausea and vomiting are clinical priorities. Its position will depend on evidence-based protocol use, dependable quality and supply, suitable formulations, regulatory compliance, and equitable access across varied healthcare systems. Artificial intelligence may strengthen decision support and operational resilience, but adoption should remain clinically governed. Organizations that align product stewardship with regional realities and patient-centered care will be better positioned to support safe and effective use.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Granisetron Market, by Dosage Form
7.1. Introduction
7.2. Injection
7.2.1. Intravenous Bolus
7.2.2. Intravenous Infusion
7.3. Oral Disintegrating Tablet
8. Granisetron Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Granisetron Market, by Application
9.1. Introduction
9.2. Chemotherapy-Induced Nausea And Vomiting
9.2.1. Acute Phase
9.2.2. Delayed Phase
9.3. Postoperative Nausea And Vomiting
9.4. Radiation-Induced Nausea And Vomiting
10. Granisetron Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Granisetron Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Hospitals
12. Granisetron Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Granisetron Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Granisetron Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Cipla Limited
16.2. Dr. Reddy’s Laboratories Limited
16.3. F. Hoffmann-La Roche Ltd
16.4. Fresenius Kabi AG
16.5. Glenmark Pharmaceuticals Limited
16.6. Hikma Pharmaceuticals PLC
16.7. Sandoz International GmbH
16.8. Sun Pharmaceutical Industries Limited
16.9. Teva Pharmaceutical Industries Limited
16.10. Viatris Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Granisetron Market, Years Considered for the Study
FIGURE 2. Global Granisetron Market, Research Design
FIGURE 3. Global Granisetron Market, Research Framework
FIGURE 4. Global Granisetron Market, Data Triangulation
FIGURE 5. Global Granisetron Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Granisetron Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 7. Global Granisetron Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Granisetron Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Granisetron Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Granisetron Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Granisetron Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Granisetron Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Granisetron Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Granisetron Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Granisetron Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Granisetron Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Granisetron Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Granisetron Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Granisetron Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Granisetron Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Granisetron Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Granisetron Market Segmentation & Coverage
TABLE 2. Global Granisetron Market Size, 2017-2032 (USD Million)
TABLE 3. Global Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 4. Global Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Intravenous Bolus Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Intravenous Bolus Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Intravenous Bolus Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Intravenous Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Intravenous Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Intravenous Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Oral Disintegrating Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Oral Disintegrating Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Oral Disintegrating Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 17. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Chemotherapy-Induced Nausea And Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Chemotherapy-Induced Nausea And Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Chemotherapy-Induced Nausea And Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Acute Phase Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Acute Phase Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Acute Phase Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Delayed Phase Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Delayed Phase Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Delayed Phase Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Postoperative Nausea And Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Postoperative Nausea And Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Postoperative Nausea And Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Radiation-Induced Nausea And Vomiting Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Radiation-Induced Nausea And Vomiting Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Radiation-Induced Nausea And Vomiting Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 40. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 50. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. North America Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. North America Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 70. North America Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 71. North America Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. North America Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. North America Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 74. North America Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 75. North America Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Latin America Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Latin America Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 78. Latin America Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 79. Latin America Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 80. Latin America Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Latin America Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 82. Latin America Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Latin America Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Europe Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 86. Europe Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 87. Europe Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 88. Europe Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Europe Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 90. Europe Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. Europe Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Middle East Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Middle East Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 94. Middle East Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 95. Middle East Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. Middle East Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Middle East Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 98. Middle East Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Middle East Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Africa Granisetron Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Africa Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 102. Africa Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 103. Africa Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. Africa Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Africa Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 106. Africa Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Africa Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Global Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. ASEAN Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 111. ASEAN Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 112. ASEAN Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. ASEAN Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. ASEAN Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 115. ASEAN Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 116. ASEAN Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. GCC Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. GCC Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 119. GCC Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 120. GCC Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. GCC Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. GCC Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 123. GCC Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. GCC Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. European Union Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. European Union Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 127. European Union Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 128. European Union Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. European Union Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. European Union Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 131. European Union Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. European Union Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. BRICS Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. BRICS Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 135. BRICS Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 136. BRICS Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. BRICS Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. BRICS Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 139. BRICS Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. BRICS Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. G7 Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. G7 Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 143. G7 Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 144. G7 Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. G7 Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. G7 Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 147. G7 Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. G7 Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. NATO Granisetron Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. NATO Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 151. NATO Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 152. NATO Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. NATO Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. NATO Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 155. NATO Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. NATO Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Global Granisetron Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States Granisetron Market Size, 2017-2032 (USD Million)
TABLE 159. United States Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 160. United States Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 161. United States Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 162. United States Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. United States Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 164. United States Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. United States Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Canada Granisetron Market Size, 2017-2032 (USD Million)
TABLE 167. Canada Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 168. Canada Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 169. Canada Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 170. Canada Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Canada Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 172. Canada Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 173. Canada Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Mexico Granisetron Market Size, 2017-2032 (USD Million)
TABLE 175. Mexico Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 176. Mexico Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 177. Mexico Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. Mexico Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Mexico Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 180. Mexico Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Mexico Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Brazil Granisetron Market Size, 2017-2032 (USD Million)
TABLE 183. Brazil Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 184. Brazil Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 185. Brazil Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. Brazil Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Brazil Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 188. Brazil Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Brazil Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. United Kingdom Granisetron Market Size, 2017-2032 (USD Million)
TABLE 191. United Kingdom Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 192. United Kingdom Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 193. United Kingdom Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. United Kingdom Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. United Kingdom Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 196. United Kingdom Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. United Kingdom Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Germany Granisetron Market Size, 2017-2032 (USD Million)
TABLE 199. Germany Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 200. Germany Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 201. Germany Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Germany Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Germany Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 204. Germany Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. Germany Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. France Granisetron Market Size, 2017-2032 (USD Million)
TABLE 207. France Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 208. France Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 209. France Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. France Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. France Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 212. France Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. France Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Russia Granisetron Market Size, 2017-2032 (USD Million)
TABLE 215. Russia Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 216. Russia Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 217. Russia Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Russia Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Russia Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 220. Russia Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Russia Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Italy Granisetron Market Size, 2017-2032 (USD Million)
TABLE 223. Italy Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 224. Italy Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 225. Italy Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 226. Italy Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Italy Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 228. Italy Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. Italy Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Spain Granisetron Market Size, 2017-2032 (USD Million)
TABLE 231. Spain Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 232. Spain Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 233. Spain Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. Spain Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Spain Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 236. Spain Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. Spain Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. China Granisetron Market Size, 2017-2032 (USD Million)
TABLE 239. China Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 240. China Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 241. China Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. China Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. China Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 244. China Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. China Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. India Granisetron Market Size, 2017-2032 (USD Million)
TABLE 247. India Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 248. India Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 249. India Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. India Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. India Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 252. India Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. India Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Japan Granisetron Market Size, 2017-2032 (USD Million)
TABLE 255. Japan Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 256. Japan Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 257. Japan Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Japan Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Japan Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 260. Japan Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Japan Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Australia Granisetron Market Size, 2017-2032 (USD Million)
TABLE 263. Australia Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 264. Australia Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 265. Australia Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 266. Australia Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Australia Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 268. Australia Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Australia Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. South Korea Granisetron Market Size, 2017-2032 (USD Million)
TABLE 271. South Korea Granisetron Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 272. South Korea Granisetron Market Size, by Injection, 2017-2032 (USD Million)
TABLE 273. South Korea Granisetron Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 274. South Korea Granisetron Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. South Korea Granisetron Market Size, by Chemotherapy-Induced Nausea And Vomiting, 2017-2032 (USD Million)
TABLE 276. South Korea Granisetron Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. South Korea Granisetron Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. Global Granisetron Market Share, by Key Player, 2025
TABLE 279. Global Granisetron Market, Key Experts

Companies Mentioned

  • Cipla Limited
  • Dr. Reddy’s Laboratories Limited
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.

Related Topics

Related Reports

Granisetron Base Market Report: Trends, Forecast and Competitive Analysis to 2035 - Product Image

Granisetron Base Market Report: Trends, Forecast and Competitive Analysis to 2035

  • Report
  • 200 Pages
  • Global
From
Granisetron (CAS 109889-09-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Granisetron (CAS 109889-09-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Chemotherapy Induced Nausea & Vomiting Treatment Market - Global Forecast 2026-2032 - Product Image

Chemotherapy Induced Nausea & Vomiting Treatment Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report - Product Image

Chemotherapy-induced Nausea and Vomiting Drugs - Global Strategic Business Report

  • Report
  • 212 Pages
  • Global
From
Tropisetron Hydrochloride Market - Global Forecast 2026-2032 - Product Image

Tropisetron Hydrochloride Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From

About the Market

Granisetron is an antiemetic drug used in the treatment of nausea and vomiting caused by chemotherapy and radiotherapy in oncology patients. It is a serotonin 5-HT3 receptor antagonist, which works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting. Granisetron is available in both oral and intravenous formulations, and is often used in combination with other antiemetics. It is generally well tolerated, with few side effects. Granisetron is used in the treatment of a variety of cancers, including breast, lung, colorectal, and ovarian cancer. It is also used to treat nausea and vomiting associated with other medical conditions, such as HIV/AIDS and postoperative nausea and vomiting. The Granisetron market is highly competitive, with a number of companies offering products in the space. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi, Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.